STOCK TITAN

SFL director holds 12,647 shares, option grants

Director James O'Shaughnessy reports direct common share holdings and multiple vested and unvested option grants in SFL Corp Ltd.

(Moderate)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

SFL Corp Ltd. (SFL) reported the initial beneficial ownership of director James O'Shaughnessy on a Form 3. As of September 14, 2026 he holds 12,647 common shares directly and several grants of share options over common shares with exercise prices between $4.25 and $10.28 and expirations from May 2026 through February 2031. The options vest in equal annual installments over three years under the issuer's Share Option Scheme and become exercisable upon vesting.

Positive

  • None.

Negative

  • None.
Insider O'SHAUGHNESSY JAMES
Role Director
Type Security Shares Price Value
holding Share options F1 -- -- --
holding Share options F2 -- -- --
holding Share options F3 -- -- --
holding Share options F4 -- -- --
holding Share options F5 -- -- --
holding Share options F6 -- -- --
holding Common Shares -- -- --
Holdings After Transaction: Share options — 166,000 contracts (Direct); Common Shares — 12,647 shares (Direct)
Footnotes (6)
  1. F1. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on May 13, 2022 and subsequent vesting on May 13, 2023 and May 13, 2024. These share options become exercisable upon vesting.
  2. F2. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 15, 2023 and subsequent vesting on February 15, 2024 and February 15, 2025. These share options become exercisable upon vesting.
  3. F3. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 14, 2024 and subsequent vesting on February 14, 2025 and February 14, 2026. These share options become exercisable upon vesting.
  4. F4. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 13, 2025 and subsequent vesting on February 13, 2026 and February 13, 2027. These share options become exercisable upon vesting.
  5. F5. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on March 12, 2026 and subsequent vesting on March 12, 2027 and March 12, 2028. These share options become exercisable upon vesting.
  6. F6. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 19, 2027 and subsequent vesting on February 19, 2028 and February 19, 2029. These share options become exercisable upon vesting.
Direct common shares held 12,647 shares Common shares held directly by James O'Shaughnessy as reported on Form 3
Option exercise price $4.25 per share Share options over 25,000 underlying common shares expiring May 13, 2026
Option exercise price $4.67 per share Share options over 30,000 underlying common shares expiring February 15, 2027
Option exercise price $7.16 per share Share options over 25,000 underlying common shares expiring February 14, 2028
Option exercise price $9.81 per share Share options over 25,000 underlying common shares expiring February 13, 2029
Option exercise price $7.52 per share Share options over 26,000 underlying common shares expiring March 12, 2030
Option exercise price $10.28 per share Share options over 35,000 underlying common shares expiring February 19, 2031
beneficial ownership financial
"reported the initial beneficial ownership of director James O'Shaughnessy"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Share Option Scheme financial
"issued pursuant to the Issuer's Share Option Scheme vest over a three-year"
underlying common shares financial
"underlying common shares per option grant are 25,000 at $4.25"
vest over a three-year period financial
"share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year"
exercisable upon vesting financial
"These share options become exercisable upon vesting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 filing reveal about SFL director James O'Shaughnessy?

It shows that James O'Shaughnessy is a director of SFL Corp Ltd. and reports his initial beneficial ownership, including 12,647 common shares held directly and several grants of share options over common shares with various exercise prices and expirations.

How many SFL (SFL) common shares does James O'Shaughnessy hold directly?

James O'Shaughnessy holds 12,647 common shares of SFL Corp Ltd. directly as reported in the Form 3. This figure reflects his direct common share ownership as of the reported date in the filing.

What share option grants over SFL common shares are reported for James O'Shaughnessy?

The Form 3 lists several share option grants over SFL common shares, including options with exercise prices of $4.25, $4.67, $7.16, $9.81, $7.52, and $10.28, each tied to specific expiration dates from May 13, 2026 through February 19, 2031.

What are the underlying share amounts for the SFL share options held by James O'Shaughnessy?

Reported underlying common shares per option grant are 25,000 at $4.25, 30,000 at $4.67, 25,000 at $7.16, 25,000 at $9.81, 26,000 at $7.52, and 35,000 at $10.28. Each grant relates to SFL common shares held through options.

How do the SFL share options for James O'Shaughnessy vest and become exercisable?

Each share option grant under SFL's Share Option Scheme vests over three years in equal one-third annual installments, with specific initial vesting dates from May 13, 2022 through February 19, 2027. The footnotes state that the options become exercisable upon vesting.

Does the Form 3 for SFL indicate any recent share purchases or sales by James O'Shaughnessy?

No buy or sell transactions are reported. The Form 3 presents holding entries only, showing existing common share and share option positions, without any coded purchase or sale transactions for the reporting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
O'SHAUGHNESSY JAMES

(Last)(First)(Middle)
C/O SFL CORPORATION LTD.
PAR-LA-VILLE PLACE, 14 PAR-LA-VILLE RD

(Street)
HAMILTONHM 08

(City)(State)(Zip)

BERMUDA

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2026
3. Issuer Name and Ticker or Trading Symbol
SFL Corp Ltd. [ SFL ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares12,647D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Share options (1)05/13/2026Common shares25,000$4.25D
Share options (2)02/15/2027Common shares30,000$4.67D
Share options (3)02/14/2028Common shares25,000$7.16D
Share options (4)02/13/2029Common shares25,000$9.81D
Share options (5)03/12/2030Common shares26,000$7.52D
Share options (6)02/19/2031Common shares35,000$10.28D
Explanation of Responses:
1. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on May 13, 2022 and subsequent vesting on May 13, 2023 and May 13, 2024. These share options become exercisable upon vesting.
2. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 15, 2023 and subsequent vesting on February 15, 2024 and February 15, 2025. These share options become exercisable upon vesting.
3. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 14, 2024 and subsequent vesting on February 14, 2025 and February 14, 2026. These share options become exercisable upon vesting.
4. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 13, 2025 and subsequent vesting on February 13, 2026 and February 13, 2027. These share options become exercisable upon vesting.
5. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on March 12, 2026 and subsequent vesting on March 12, 2027 and March 12, 2028. These share options become exercisable upon vesting.
6. The share options issued pursuant to the Issuer's Share Option Scheme vest over a three-year period in increments of 1/3 per annum with initial vesting on February 19, 2027 and subsequent vesting on February 19, 2028 and February 19, 2029. These share options become exercisable upon vesting.
/s/ James O'Shaughnessy09/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading